Table 2 |
|||
|
Baseline characteristics of mothers in the URECA study with and without lymphocyte proliferation data |
|||
|
Total (n = 82) |
With Data (N = 52) |
Without Data (N = 30) |
|
|
|
|||
|
N (%) |
N (%) |
||
|
|
|||
|
Race/ethnicity |
|||
|
Hispanic |
24 (29.6) |
16 (31.4) |
8 (26.7) |
|
Black |
40 (49.4) |
20 (39.2) |
20 (66.7) |
|
White/Asian/Other |
7 (8.6) |
6 (11.8) |
1 (3.3) |
|
More than one race |
10 (12.4) |
9 (17.7) |
1 (3.3) |
|
Atopic disease |
|||
|
Eczema |
30 (37.0) |
19 (37.3) |
11 (36.7) |
|
Asthma* |
48 (60.0) |
26 (51.0) |
22 (75.9) |
|
Hay fever |
39 (49.4) |
27 (55.1) |
12 (40.0) |
|
Intake of steroids during pregnancy |
18 (22.0) |
11 (21.2) |
7 (23.3) |
|
Mean (SD) |
|||
|
Age |
26.1 (6.7) |
26.9 (7.2) |
24.7 (5.7) |
|
|
|||
|
* Statistically significant difference between mothers with and without lymphocyte proliferation data, p < 0.05. |
|||
|
Ly et al. Clinical and Molecular Allergy 2009 7:8 doi:10.1186/1476-7961-7-8 |
|||
